DEUTSCHE BANK AG\
BankPosition in CLDX — Celldex Therapeutics, Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in CLDX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$6,570,987
+$2,033,854 QoQ
Shares Held
176,592
+23.5% QoQ
Ownership
0.225%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 252 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 55%
Shared 0%
None 45%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. CLDX ranks #55 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in CLDX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,570,987 | 176,592 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $4,537,133 | 143,037 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $3,706,932 | 136,485 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $3,480,989 | 134,557 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,616,623 | 128,581 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $2,509,944 | 138,289 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $3,070,329 | 121,501 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $1,341,210 | 39,459 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $1,646,315 | 44,483 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $1,926,087 | 45,892 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $1,440,252 | 36,315 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,024,321 | 37,221 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $1,153,891 | 34,008 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,623,704 | 45,128 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,618,915 | 36,323 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $942,022 | 33,512 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,588,968 | 170,214 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $2,549,628 | 74,857 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,782,699 | 97,896 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $2,443,531 | 45,259 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $1,158,059 | 34,631 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $49,604 | 2,408 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,440,704 | 82,232 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $5,847,068 | 394,273 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||